TSPAN32 and chronic myelogenous leukemia, BCR-ABL1 positive: By analyzing CML patient scRNA-seq data obtained from public datasets, we found that the expression of TSPAN32 was decreased in the LSCs of newly diagnosed CML patients compared the HSCs from healthy donors.